LASIK induces irregular astigmatism

Article

Unlike LASEK, LASIK significantly increases irregular astigmatism in the 3 and 5 mm central zones.

Unlike LASEK, LASIK significantly increases irregular astigmatism in the 3 and 5 mm central zones, according to Liliana Voinea and co-workers from the Optilaser Medical Center, Bucharest, Romania.

One hundred and three eyes undergoing LASIK (55 eyes) and LASEK (48 eyes) for myopia were evaluated. Corneal topography was performed preoperatively and six months following surgery. The Orbscan II videokeratoscope was used to obtain irregular astigmatism values in the 3 and 5 mm central zone.

Following LASIK, the researchers noted a statistically significant increase in the value of the irregular astigmatism in the 3 mm central zone (p=0.05, t=3.67) and 5 mm central zone (p=0.05, t=2.89). LASEK however, did not induce a statistically significant increase in these two parameters.

A direct correlation was also observed between the dioptric value of the myopia and the value of the irregular astigmatism following LASIK.

The researchers concluded that LASIK significantly increases the irregular astigmatism in the 3mm and 5 mm central zones.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.